Psylo
About:
Psylo is a drug development company that focuses on next-generation psychedelics.
Website: https://psylo.bio
Top Investors: Gaingels, Main Sequence Ventures, Possible Ventures, Empath Ventures, Lionheart Ventures
Description:
Psylo is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications.
Total Funding Amount:
$15M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Sydney, New South Wales, Australia
Founded Date:
2021-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-10-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai